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Abstract
We present the synthesis of the two novel nucleosides iso-tc-T and bcen-T, belonging to the bicyclo-/tricyclo-DNA molecular plat-
form. In both modifications the torsion around C6’–C7’ within the carbocyclic ring is planarized by either the presence of a
C6’–C7’ double bond or a cyclopropane ring. Structural analysis of these two nucleosides by X-ray analysis reveals a clear prefer-
ence of torsion angle γ for the gauche orientation with the furanose ring in a near perfect 2’-endo conformation. Both modifications
were incorporated into oligodeoxynucleotides and their thermal melting behavior with DNA and RNA as complements was
assessed. We found that the iso-tc-T modification was significantly more destabilizing in duplex formation compared to the bcen-T
modification. In addition, duplexes with complementary RNA were less stable as compared to duplexes with DNA as complement.
A structure/affinity analysis, including the already known bc-T and tc-T modifications, does not lead to a clear correlation of the
orientation of torsion angle γ with DNA or RNA affinity. There is, however, some correlation between furanose conformation (N-
or S-type) and affinity in the sense that a preference for a 3’-endo like conformation is associated with a preference for RNA as
complement. As a general rule it appears that Tm data of single modifications with nucleosides of the bicyclo-/tricyclo-DNA plat-
form within deoxyoligonucleotides are not predictive for the stability of fully modified oligonucleotides.
Introduction
Antisense oligonucleotides (ASOs) can interfere with gene
expression via various biological mechanisms, depending on the
nature of the cellular RNA target [1]. First and foremost they
can inhibit translation by targeting a mature mRNA in either its
coding or non-coding part of the sequence by a steric block or
an RNase H dependent degradation mechanism. Furthermore, it
has recently been shown that ASOs can alter RNA splicing
when targeting exon/intron junctions or splice enhancer or
silencer binding sites on pre-mRNAs, thus leading to alter-
native splicing [2,3], to exon skipping [4,5] or to exon inclu-
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sion [6]. In addition they can restore the function of mRNAs
containing extended aberrant repeat sequences in their non-
coding region by either restoring correct cellular localization or
inhibiting vital protein sequestration by the aberrant repeats [7].
Last but not least, there is an ever growing number of micro
RNAs (miRNAs) that are involved in genetic and epigenetic
regulation of gene expression. Their misregulation stays at the
onset of various forms of cancer and other metabolic diseases,
and targeting of such miRNAs with ASOs (antimirs or
anatagomirs) has been shown in the recent past to be a
promising therapeutic principle [8].
There exists a multitude of chemical modifications in ASOs.
Historically, the first modification was the replacement of the
phosphodiester linking units in DNA by phosphorothioate
groups, thus conferring higher metabolic stability to ASOs in
plasma and tissue [9,10]. Another site of modification is the
2’-OH group of RNA that can be equipped or replaced with
various chemical entities typically aiming at higher affinities to
the corresponding RNA targets [11-14]. More diverse analogues
include structures in which the sugar phosphate backbone has
been replaced by a charge neutral peptide backbone, such as the
peptide nucleic acids (PNAs) [15] or by a nucleotide derived
phosphorodiamidate backbone, such as the morpholino oligonu-
cleotides (PMOs) [16]. Of particular interest is the class of
conformationally constrained oligonucleotides. Members of this
class are amongst others the locked nucleic acids (LNA)
[17,18], the hexose nucleic acids (HNAs) [19] and the family of
bi- and tricyclo-DNA (Figure 1) [20-23]. These analogues aim
at increasing RNA affinity by structurally preorganizing single
strands for duplex formation.
Bc- and tc-DNA have been conceived to reduce the entropy
upon duplex formation with a nucleic acid target by reducing
the conformational flexibility around the C3’–C4’ and C4’–C5’
bonds, while achieving as much as possible of a geometric
match with the backbone conformation of DNA in duplexed
form. From this a gain in the free energy of duplex formation
and, hence, more stable duplexes are expected [24]. Over the
years we became interested in determining the structure/RNA
affinity relationship of the underlying sugar scaffold and to
develop them into a molecular platform for oligonucleotide
therapeutics. Given the exclusiveness of the ethylene bridge
between the centers 3’ and 5’ with respect to DNA or RNA we
have identified this structural element to be the primary goal for
chemical modification [25-30]. In continuation of this work we
decided to investigate on two novel thymine nucleosides with
restricted conformation of the C6’–C7’ bond, namely bcen-T
and iso-tc-T (Figure 1). Here we present the synthesis and
X-ray structural characterization of the respective nucleosides,
their incorporation into oligodeoxynucleotides by phosphor-
Figure 1: Chemical structures and carbon numbering scheme of
tricyclo(tc)-DNA (top, left), bicyclo(bc)-DNA (top, right) and the newly
synthesized iso-tricyclo(iso-tc)-DNA (bottom, left) and bicyclo-en(bcen)-
DNA (bottom, right).
amidite chemistry as well as the DNA and RNA affinity profiles
of the modified oligonucleotides.
Results
Synthesis of building blocks
The synthesis of the phosphoramidite 10 started with the
bicyclic intermediate 1 that had previously been described on
the way to related bicyclo-DNA derivatives (Scheme 1) [30].
Following an obvious synthetic strategy, compound 1 was
subjected to carbonyl reduction which occurred with high
stereoselectivity from the less hindered, convex side of the
bicyclic system, resulting in alcohol 2 along with traces of its
epimer. To increase the stereoselectivity of the upcoming cyclo-
propanation reaction it seemed appropriate to protect the sec-
ondary hydroxy group as TBS ether (→ 3). Indeed cyclopropa-
nation of 3 with diethylzinc and CH2I2 proceeded stereospecifi-
cally, again from the convex side of the bicyclic system, to give
4. Subsequent nucleosidation of 4 via the Vorbrüggen proce-
dure [31,32] with transient protection of the tertiary hydroxy
group in 4 as TMS ether, however, was unsuccessful and
yielded only the corresponding α-nucleoside in yields below
25%. We reasoned that the exclusive formation of α-nucleo-
sides is due to the steric bulk of the TBS group, further
suppressing the intrinsically disfavored β-(endo)-face attack of
the base. To counterbalance these effects we chose to protect
the tertiary hydroxy group as a pivaloyl ester thus increasing the
steric bulk on the α-face, and relieving that on the β-face by
replacing the TBS by a transient TMS group. The conversion of
4 → 6 proceeded smoothly and indeed, the use of compound 6
as nucleobase acceptor improved the yield of nucleosides 7α,β
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Scheme 1: Conditions: (a) NaBH4, CeCl3·7H2O, MeOH, −78 °C → rt, 1.5 h, 73% (+9% of C6-epimer); (b) TBS-Cl, imidazole, CH2Cl2, rt, 16 h, 79%;
(c) Et2Zn in hexane (1 M), CH2I2, CH2Cl2, 0 °C → rt, 16 h, 86%; (d) PivCl, DMAP, pyridine, ClH2C–CH2Cl, 70 °C, quant.; (e) TBAF, THF, rt, 19 h,
95%; (f) thymine, BSA, SnCl4, CH3CN, 0 °C → rt, 17 h, 56% 7β + 22% (7α/β 2.5:1); (g) Bu4NOH, H2O/dioxane, rt, 16 h, 94%; (h) DMTrCl, pyridine,
CH2Cl2, rt, 24 h, 98%; (i) CEP-Cl, DIPEA, THF, rt, 4 h, 89%.
Scheme 2: Conditions: (a) thymine, BSA, TMSOTf, TMSCl, CH3CN, rt, 2.5 h; (b) DMTrCl, pyridine, rt, 16 h, 29% of 12α and 34% of 12β (over two
steps); (c) CEP-Cl, DIPEA, THF, rt, 1 h, 94%.
in general and led to an acceptable β:α = 2.5:1 ratio of anomers.
Subsequent saponification of 7α,β (unseparable by flash chro-
matography) proved to be tricky and after testing a series of
standard techniques, only treatment with Bu4NOH in a mixed
organic/aqueous solvent gave nucleosides 8α,β in good yield. It
was at this step where the two anomers could be readily sep-
arated by flash chromatography. Continuing with 8β the syn-
thesis of 10 was concluded by standard tritylation (→ 9) and
phosphitylation.
To extend on the structure/nucleic acid affinity profile of this
modification we also became interested in nucleoside 11β,
containing a double bond instead of the cyclopropane ring. In
the context of oligonucleotides this derivative seemed appro-
priate to investigate the direct steric influence of the cyclo-
propyl/methylene group in a bicyclic sugar scaffold that is
otherwise very similar in flexibility and geometry. The corres-
ponding building block 13 (Scheme 2) was easily available via
nucleosidation of sugar intermediate 2 (in situ TMS protection
of both hydroxy groups) leading to the mixture of anomeric
nucleosides 11α,β in a ratio of β:α = 1.2:1. After standard trity-
lation of 11α,β the anomeric mixture 12α,β became separable
by flash chromatography and the corresponding β-nucleoside
12β could be smoothly converted into the phosphoramidite 13
by standard methods.
Structural properties of nucleosides
To get an independent proof on the relative configuration
around the cyclopropane ring and the glycosidic bond and to
obtain insight into the conformational properties of the central
bicyclic sugar scaffold, crystals of 8β and 11β were grown and
subjected to X-ray analysis (Figure 2, Table 1). It clearly
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Figure 2: X-ray structure of top row: nucleosides 8β (left), 11β (center) and overlay of both structures (right); bottom row: tc-T (Mol A, left, Mol B,
right).
emerges that in both nucleosides the furanose unit appears in an
almost perfect 2’-endo conformation giving rise to a trans
arrangement of torsion angle δ (O3’–C3’–C4’–C5’). In both
structures the cyclopentane ring exists in a shallow envelope
conformation with C5’ being slightly out of plane. This leads to
a gauche orientation of torsion angle γ (C3’–C4’–C5’–O5’). In
both structures the base thymine is, as expected, in the anti-
orientation. The overlay of both structures clearly highlights the
similarity of both structures, indicating that the extra methylene
group in 8β plays no direct role in controlling the conformation
of the bicyclic ring system.
Table 1: Selected backbone torsion angles and sugar pucker data for
8β and 11β and related bi/tricyclo-nucleosides from X-ray structures.
γ δ χ P νmax
8β 86.8° 150.1° −106.4° 167.8° 36.1
11β 86.9° 146.0° −115.7° 160.7° 36.3
bc-Ta 149.3° 126.5° −112.7° 128.4° 42.4
tc-Tb Mol A 125.0° 152.5° −130.4° 172.2° 36.7
tc-Tb Mol B 154.8° 98.7° −120.3° 94.4° 36.0
aRef [33]; btwo structurally independent molecules per asymmetric
unit.
A comparison of 8β and 11β with bc-T, having a saturated
cyclopentane unit clearly reveals structural differences. The
largest deviation is associated with the position of the 5’-OH
group which is in a pseudoequatorial orientation in bc-T, giving
rise to a torsion angle γ in the anticlinal range. The saturation of
the carbocyclic ring translates to a lesser extent also into the
furanose ring where a 1’-exo instead of a 2’-endo conformation
is observed in bc-T. Both furanose conformations, however,
belong to the S-type and are thus structurally related in the
context of nucleic acid duplex conformation. Quite interest-
ingly, the original tc-T nucleoside [34], for which we solved the
X-ray structure here for the first time (Figure 2), shows consid-
erable conformational variability in the furanose part. The
asymmetric unit contains two independent molecules (Mol A
and Mol B) of which the furanose part in Mol A adopts a
2’-endo (S-type) conformation, while in Mol B a 4’-endo
(N-type) conformation is observed. In summary it appears that
rigidifying and planarizing the C5’–C6’-bond as in tc-nucleo-
sides leads to an anticlinal orientation of torsion angle γ and
variability between S- and N-type in the furanose conformation,
whereas rigidifying and planarizing the C6’–C7’-bond, as in 8β
and 11β, leads to a synclinal torsion angle γ and a consistent
2’-endo furanose conformation. Saturation of the carbocyclic
ring, as in bc-T, leads to an anticlinal arrangement of γ and a
somewhat attenuated but clear preference for an S-type fura-
nose conformation.
Oligonucleotide synthesis
The dodecamers ON1–4, shown in Table 2, containing one to
two modifications, were synthesized in order to test the conse-
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Scheme 3: Pathways for elimination of the modified nucleotides during the oxidation step in oligonucleotide assembly.
quences of the two modified bicyclic nucleotides on RNA and
DNA affinity. ON5–7, containing the known tc-T residues in
the respective positions, were synthesized for comparison.
ON1–3 were assembled on the 1.3 μmol scale on a DNA
synthesizer utilizing standard phosphoramidite chemistry proto-
cols first. The trityl assay after incorporation of 13 and the
subsequent building block revealed typically a drop of syn-
thesis yield by roughly 20%. This was also reflected in the
HPLC traces after final cleavage from the solid support (33% aq
NH3, 55 °C, 16 h) which revealed besides the expected oligonu-
cleotides ON1–3 also truncated sequences corresponding to
5’-phosphorylated fragments arising from cleavage 3’ to the
modification as determined by mass spectrometry. Re-subjec-
tion of the isolated full length oligonucleotides ON1–3 to
deprotection conditions did not lead to any further degradation,
suggesting that E1 elimination of the 3’-P-unit occurs during
the oxidation step of the modified residues, most likely on the
level of the iodinated phosphite intermediate [35], leading to the
formation of an allylic carbocation in the bcen-T unit and
5’-phosphorylated DNA fragment (Scheme 3).
The synthesis of oligonucleotides using building block 10
proved to be even more difficult. Using the standard phosphor-
amidite protocol, the oligonucleotide synthesis failed
completely at the site of modification and not even traces of a
full length oligonucleotide could be observed after chain
assembly and deprotection. Only 5’-phosphorylated, truncated
oligonucleotide fragments could be isolated. We reasoned that
oxidation with iodine followed by E1 elimination of the 3’-P-
unit happend also in this case, leaving behind an alpha-cyclo-
propyl cation that undergoes subsequent rearrangement
(Scheme 3). The fact that elimination is quantitative in the iso-
tc-T case may be explained by the release of ring strain during
cyclopropyl rearrangement which contributes to the stabiliza-
tion of the E1 transition state. Based on these assumptions we
changed the oxidant from iodine to t-BuOOH, which has
successfully been used in the past in the allyloxycarbonyl base-
and phosphate protecting scheme for oligonucleotide synthesis
[36]. Under these conditions, full length oligonucleotide ON4
could be isolated in 80% as determined by trityl assay. Due to
limited availability of the phosphoramidite building block 10,
only this particular oligonucleotide could be obtained in suffi-
cient quantities for biophysical experimentation.
Tm data
To assess DNA and RNA affinity of the two novel modifica-
tions we measured UV-melting curves at 260 nm. With a
gradient of 0.5 °C/min the heating and cooling curves are super-
imposable, indicating equilibrium conditions and excluding de-
gradation of the modified oligonucleotides under the conditions
of measurement. The corresponding Tm-data are summarized in
Table 2.
The bcen-T modification destabilizes duplexes with comple-
mentary DNA by −1.4 to −2.0 °C per modification relative to
dT in a somewhat sequence dependent context. If flanked by
two pyrimidine nucleotides (ON1) the destabilization is higher
as compared to purines as nearest neighbors (ON2). Two
consecutive residues lead to less destabilization which is in line
with earlier observations on tc-DNA where it was found that the
highest Tm/modification were observed in fully modified
oligonucleotides [37]. Duplexes with RNA as complement are
also destabilized albeit to a lesser extent (ΔTm/mod −0.8 to
−2.2 °C). The same sequence dependence as for DNA as
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Table 2: Sequence information and analytical data of ON1–7 as well as Tm data from UV-melting curves (260 nm) in 10 mM NaH2PO4/Na2HPO4,
150 mM NaCl, pH 7.0. Duplex concentration: 1.2 μM.
Sequence Modification t Tm vs DNAa Tm vs RNAa
ON1 d(GGATGTTCtCGA) 45.3 (−2.0) 45.6 (−2.2)
ON2 d(GGAtGTTCtCGA) 43.9 (−1.7) 45.0 (−1.4)
ON3 d(GGATGttCTCGA) 44.4 (−1.4) 46.2 (−0.8)
ON4 d(GGATGTTCtCGA) 44.8 (−2.5) 43.0 (−4.8)
ON5 d(GGATGTTCtCGA) 45.8 (−1.6) 46.6 (−1.2)
ON6 d(GGAtGTTCtCGA) 46.8 (−0.3) 46.8 (−0.5)
ON7 d(GGATGttCTCGA) 47.2 (−0.1) 49.6 (+0.9)
aTm of unmodified duplex d(GGATGTTCTCGA): 47.3 °C vs DNA; 47.8 °C vs RNA; ΔTm per modification in parenthesis.
complement appears and again, two consecutive modifications
are associated with the least depression in Tm/modification.
Thus, it turns out that bcen-DNA prefers RNA over DNA as a
complement which is remarkable given that the parent nucleo-
side adopts a 2’-endo (S-type) sugar conformation and not a
3’endo (N-type) as do modifications that typically prefer RNA
as complement (e.g., LNA). This is somewhat similar to obser-
vations with the α-L-LNA analogue which also prefers RNA
over DNA as complement despite being a DNA mimic [38].
Also the iso-tc-T modification (ON4) turns out to destabilize
duplexes with complementary DNA and RNA. However, in
contrast to the bcen-modification, where there is essentially no
difference in binding to DNA and RNA, destabilization of DNA
as complement is lower (ΔTm −2.5 °C) while that of RNA is
higher (ΔTm −4.8 °C), this despite the fact that the sugar confor-
mations of the monomers (see Figure 2) are virtually identical.
The differential behavior therefore has to be attributed to steric
effects of the cyclopropyl methylene group on the adjacent
3’-phosphodiester function solely.
Discussion
The two novel bc-/tc-modifications presented in this work are
part of our endeavor to understand the structure/affinity rela-
tionship of this particular oligonucleotide molecular platform in
more detail. More precisely we aimed with these modifications
to learn how subtle structural changes influence not only the
backbone torsion angle γ but also control the conformation of
the furanose ring which is central for duplex structure and
stability. From X-ray analysis of monomers (Table 2) we find
that planarizing the C5’–C6’-bond (tc-nucleosides) leads to a
trans orientation of torsion angle γ and some variability
between S- and N-type furanose conformation, compared to the
ring-saturated bc-nucleosides which have a stronger preference
for S-type furanose conformation and also maintain the prefer-
ence for the trans orientation of torsion angle γ. On the other
hand, planarizing the C6’–C7’-bond, as in 8β and 11β, leads to
a synclinal torsion angle γ and a consistent 2’-endo furanose
conformation.
In order to correlate structural features of the four monomers
under discussions with thermal affinity of correspondingly
modified oligonucleotides we have summarized the ΔTm/modi-
fication data for RNA and DNA binding of the four modifica-
tions within the same sequence context for which data was
available (Table 3). From the data it becomes evident that there
is no clear correlation between torsion angle γ and affinity. For
example bcen-T, having γ in the for duplexes natural gauche
orientation, is more destabilizing than bc-T in which it is clearly
in the unnatural trans orientation. However, there seems to be
Beilstein J. Org. Chem. 2014, 10, 1840–1847.
1846
Table 3: ΔTm/modification data for four different bi/tricyclo modifications in one sequence context.
d(GGATGTTCtCGA)
t =
ΔTm/modification vs
DNA [°C]
ΔTm/modification vs
RNA [°C]
furanose pucker torsion angle γ
bc-Ta +1.5 −0.5 1’-exo trans
bcen-T −2.0 −2.2 2’-endo gauche
tc-T −1.6 −1.2 2’-endo/
4’-endo
trans
trans
iso-tc-T −2.5 −4.8 2’-endo gauche
aRef. [27].
some correlation between the furanose pucker and affinity.
There is a trend that nucleosides preferring an S-type sugar con-
formation (bc-T, bcen-T, iso-tc-T) prefer a DNA over an RNA
complement. In the only nucleoside that shows some 3’-endo
(N-type) character (tc-T) this is inverted. Probably the clearest
correlation can be made regarding the effect of the cyclo-
propane ring in iso-tc-T. Compared to bcen-T, it becomes clear
that the additional CH2 group destabilizes duplexes in an other-
wise isostructural scaffold. This is most likely due to unfavor-
able steric interactions with the 3’-phosphate group. This nega-
tive effect is not unexpectedly most pronounced with RNA as a
complement (A-type helical structure).
It has to be clearly noted here that an analysis based on single
incorporations of bc- or tc-modifications does not necessarily
reflect the effect of the same residues in fully modified oligonu-
cleotides. For example, a bc-T residue stabilizes a duplex with
complementary DNA in the above sequence context. However,
a fully modified bc-oligonucleotide has no stabilizing effect
upon binding to a DNA or RNA complement [20]. Along the
same lines, a tc-T residue in the above sequence context desta-
bilizes duplexes with both a DNA and an RNA complement. On
the other hand fully modified tc-oligonucleotides stabilize
duplexes with DNA and RNA by 1–3 °C per modification [37].
It thus appears that every modification of the DNA or RNA
backbone with a bc- or tc-residue is associated with an ener-
getic penalty which most likely arises from the local structural
perturbation of the backbone at the site of modification. The
more homogeneous the backbone becomes, the more dominant
is the energetic benefit (or penalty) of the modification.
Conclusion
We have synthesized the two novel, thymine containing bc-/tc-
nucleosides 8 and 11β and incorporated them into oligodeoxy-
nucleotides. Analysis of the monomers by X-ray spectroscopy
clearly show a high degree of similarity in the conformation of
the underlying bicyclic scaffold of these two nucleosides.
Thermal melting analysis of duplexes shows a destabilization
with both DNA and RNA as complements. The destabilization
is more expressed with the iso-tc-T unit and is due to steric
interactions of the extra-CH2 group of the cyclopropane ring
with the adjacent 3’-phosphate unit. A structure/affinity analysis
including the known bc-T and tc-T nucleosides suggests that it
is less the structural variety of torsion angle γ but more the fura-
nose pucker (2’-endo vs 3’-endo) that governs affinity. Further-
more, from the accumulated set of Tm data available it becomes
clear that ΔTm/modification data from oligonucleotides with
single incorporations of members of the bc/tc-DNA family in
general do not reflect the affinity profile of the corresponding
fully modified oligonucleotides.
Supporting Information
Experimental procedures and analytical data, including
copies of 1H, 13C and 31P NMR spectra (where
appropriate) for all new compounds as well as details for
oligonucleotide synthesis and thermal melting experiments.
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